Navigation Links
ACEA Biosciences Introduces an Exploratory xCELLigence® RTCA S16 Instrument
Date:7/31/2018

ACEA Biosciences, is a privately owned biotechnology company which develops cutting edge instrumentation for cell analysis. The company has just introduced the xCELLigence RTCA S16, which the ideal entry level model for exploratory studies in cell biology.

Controlled and monitored via an external computer, the S16can be placed in any standard CO2 tissue culture incubator. The user friendly RTCA software allows for real-time control and monitoring of cell biology in action, and displays real-time kinetic data with a plethora of analysis functions. Indeed, the system can monitor the impact of new drugs, viruses, bacteria, and co-culture assays, making the system ideal for studies in new drug discovery, vaccine development, and immunotherapy.

“We are moving away from the iPad-based iCELLigence platform because Apple’s continuous and frequent iOS upgrades have been causing compatibility issues with our RTCA software,” explained Jeff Xue, Ph.D., Marketing Director at ACEA Biosciences. “The new S16 model is a PC Windows-based platform ideal for assay development and optimization. Users can run one 16-well plate on the S16 instead of two 8-well plates,” added Dr. Xue. “The S16 model is compatible with ACEA’s existing E-Plate® 16, E-Plate View 16, and E-Plate 16 PET.”

For existing iCELLigence owners, ACEA Biosciences is offering a 20% discount on a new PC laptop (control unit), a free USB cable, and free software (up to 3 seats). The iCELLigence version of consumables (E-Plate L8 and E-Plate L8 PET) and parts will continue to be offered by ACEA for an extended period of time..

To learn more about S16, click here.

About xCELLigence® Real Time Cell Analysis (RTCA)
ACEA’s xCELLigence RTCA instruments are being used in both academia and industry for life science applications ranging from cancer immunotherapy, bacterial biofilms, vaccine development and cardiotoxicity testing. With the xCELLigence technology, scientists can non-invasively monitor the behavior of cells by quantifying cell proliferation, morphology change, and attachment quality in a label-free, real-time manner.

About ACEA Biosciences
Founded in 2002, ACEA Biosciences is a pioneer in the development and commercialization of high performance cell analysis platforms for life science research. ACEA’s xCELLigence® Real-Time Cell Analysis instruments and NovoCyte® flow cytometer are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research. More than 2,500 instruments have been placed globally, and have been used in more than 1,800 peer-reviewed publications, which can be viewed in a searchable library.

For more information visit: http://www.aceabio.com.

Follow on LinkedIn, Twitter, and Facebook

For further information please contact:                                                                                    
ACEA Biosciences, Inc.                                                                                                                
Dr. Jeff Xue                                                                                                                                    
Phone: 1-858-299-8023                                                                                            
email: jxue(at)aceabio(dot)com

Read the full story at https://www.prweb.com/releases/acea_biosciences_introduces_an_exploratory_xcelligence_rtca_s16_instrument/prweb15661631.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Pressure BioSciences Closes Additional $745,000 of $5 Million PIPE; Funding Received to Date Exceeds $4,000,000
2. The new Africa -- green shoots in biosciences
3. Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
4. Wellspring Biosciences Founder Publishes In Nature On Discovery of Small Molecule Inhibitors of K-Ras
5. Springer will publish lecture series with the Mathematical Biosciences Institute
6. Robbins Geller Rudman & Dowd LLP and Scott+Scott, Attorneys at Law, LLP Announce Proposed Settlement of Class Action in the Pacific Biosciences Securities Litigation
7. Inflection Biosciences licenses preclinical oncology programs from the CNIO
8. Delta ID Introduces Iris Scanning Technology for In-Car Biometrics and Secure Autonomous Driving at CES 2017
9. Continental Introduces Biometrics to Vehicles at CES 2017
10. Cercacor Introduces Ember Sport Premium
11. A&D Medical Introduces Its LifeSource UltraConnect Wireless Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2018)... FRANCISCO (PRWEB) , ... August ... ... provider of advanced software solutions for biopharma R&D, today announced that Seattle-based ... their preferred bioinformatics solution provider. Aptevo will use the Genedata Biologics ...
(Date:8/17/2018)... N.J. and LIEGE, Belgium (PRWEB) , ... ... ... Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider ... services including a number of targeted DNA methylation assays using pyrosequencing or ...
(Date:8/17/2018)... ROCK, Colo. (PRWEB) , ... August 16, 2018 , ... ... facioscapulohumeral muscular dystrophy (FSHD), announced that its Colorado Chapter will be holding its ... scheduled for September 8th at the Philip S. Miller Park, advocates for public awareness ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... (PRWEB) , ... September 11, 2018 , ... ... at the American Association of Feline Practitioners Conference (AAFP) later this ... data on adipose-derived stem cell therapy for the treatment of chronic kidney disease ...
(Date:9/7/2018)... ... 06, 2018 , ... The Discovery on Target (DOT) conference ... industry’s preeminent event on novel drug targets.” BellBrook Labs’ high throughput screening (HTS) ... emerging targets in a quest to find new treatments for disease. , BellBrook ...
(Date:9/1/2018)... ... 2018 , ... Rudina Thanasi, a scientifically validated holistic energy ... treated nutraceutical supplement used in combating inflammation and autoimmune disorders. , ... as, organ-specific inflammation. The reported data is as follows: , More than ...
(Date:8/29/2018)... , ... August 28, 2018 , ... Cognition Corporation ... full lineup of talks for NAVIGATE2018 . , Ryan Ward, Director of ... Cognition’s annual user conference. An experienced engineer and manager with Zimmer Biomet for almost ...
Breaking Biology Technology: